What is Avalo Therapeutics's gross profit?

Avalo Therapeutics (AVTX) reported gross profit of $963K in Q3 2024.

How has Avalo Therapeutics's gross profit changed year-over-year?

Avalo Therapeutics's gross profit increased by 8854.5% year-over-year, from -$11K to $963K.

What is the long-term trend for Avalo Therapeutics's gross profit?

Over 2 years (2021 to 2023), Avalo Therapeutics's gross profit has grown at a -60.5% compound annual growth rate (CAGR), from $4.11M to $640K.

What does gross profit mean?

Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.

Avalo Therapeutics AVTX Gross Profit

Discontinued — last reported Q3 '24

Gross Profit at other companies

Eli LillyLLY

$16.22B+54.4%

AbbVieABBV

$10.78B+15.4%

Aurinia PharmaceuticalsAUPH

$71.2M+32.1%

Kiniksa Pharmaceuticals International, plcKNSA

$193.47M+61.3%

ImmunityBio, Inc.IBRX

——

TG TherapeuticsTGTX

——

Other financials

Income statement

See full

Revenue$59.0K-69.3%

Operating income-$20.9M-42.5%

Net income-$19.6M-49.3%

EPS (diluted)-$0.98+21.6%

Balance sheet

See full

Cash & equivalents$25.3M-79.8%

Total debt$328.0K-59.1%

Total equity$68.3M-44.3%

Total assets$99.9M-27.9%

Cash flow

See full

Operating cash flow-$17.7M-87.1%

CapEx-—

Free cash flow-$15.0M-444%

Valuation

See full

Market cap$954.59M+1,800%

Enterprise value$929.6M-1,353%

P/S1,909.2×+1,868×

Profitability

See full

Gross margin182%+176pp

Operating margin-15,536.1%-17,275pp

Net margin-7,965.8%-10,750pp

FCF margin-11,123.8%-13,374pp

Returns & leverage

See full

Return on equity-88.8%—

Debt / equity0×0.0×

Current ratio7.7×-14.9×

Where this comes from

Calculated from Avalo Therapeutics’s reported figures.

$249.0Ktotal revenue+$714.0Ktotal cost of revenue=$963K

The official record: Avalo Therapeutics’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Avalo Therapeutics's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Avalo Therapeutics's gross profit?: Avalo Therapeutics (AVTX) reported gross profit of $963K in Q3 2024.
How has Avalo Therapeutics's gross profit changed year-over-year?: Avalo Therapeutics's gross profit increased by 8854.5% year-over-year, from -$11K to $963K.
What is the long-term trend for Avalo Therapeutics's gross profit?: Over 2 years (2021 to 2023), Avalo Therapeutics's gross profit has grown at a -60.5% compound annual growth rate (CAGR), from $4.11M to $640K.
What does gross profit mean?: Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.